Citius Oncology, Inc. CTOR Book value per share
Book value per share at other companies
Other financials
Where this comes from
Calculated from Citius Oncology, Inc.’s reported figures.
Based on the most recent quarter.
The official record: Citius Oncology, Inc.’s 10-Q, filed May 15, 2026, on SEC EDGAR. View the filing →
Ask your AI about Citius Oncology, Inc.'s book value per share.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Citius Oncology, Inc.'s book value per share?
- Citius Oncology, Inc. (CTOR) reported book value per share of $0.35 in Q1 2026.
- How has Citius Oncology, Inc.'s book value per share changed year-over-year?
- Citius Oncology, Inc.'s book value per share decreased by 29.2% year-over-year, from $0.50 to $0.35.
- What is the long-term trend for Citius Oncology, Inc.'s book value per share?
- Over 3 years (2022 to 2025), Citius Oncology, Inc.'s book value per share has grown at a -70.6% compound annual growth rate (CAGR), from $24.18 to $0.61.
- What does book value per share mean?
- Shareholders' equity divided by diluted shares outstanding at the quarter end. The accounting (book) value attributable to each share.